Evidence map›Paper›PMID 29247574›Full record

ArticleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2018

IgE promotes type 2 innate lymphoid cells in murine food allergy.

O T Burton, J Medina Tamayo, A J Stranks, S Miller, K J Koleoglou, E O Weinberg, H C Oettgen

Open access · bronzeAbstract read
In one paragraph

Article in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 81 citations in OpenAlex.

  1. Emerging Paediatric Uses of Dupilumab Beyond Approvals.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026
    Review
  2. Mast cell-derived extracellular vesicles in lung diseases: roles in pulmonary inflammation, immune regulation, and microenvironmental remodeling.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  3. Context-dependent regulation of mast cell-mediated food allergy in C57BL/6J mice.The Journal of allergy and clinical immunology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Clinical & translational immunology · 2024
    Review
  9. Review
  10. Review
  11. Article
  12. Exploring potential pharmacological mechanisms ofAnnals of medicine and surgery (2012) · 2023
    Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. ILCs and Allergy.Advances in experimental medicine and biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

O T BurtonDepartment of Medicine, Boston Children's Hospital, Boston, MA, USA.ORCID 0000-0003-3884-7373
J Medina TamayoDepartment of Medicine, Boston Children's Hospital, Boston, MA, USA.
A J StranksDepartment of Medicine, Boston Children's Hospital, Boston, MA, USA.
S MillerDepartment of Medicine, Boston Children's Hospital, Boston, MA, USA.
K J KoleoglouDepartment of Medicine, Boston Children's Hospital, Boston, MA, USA.
E O WeinbergDepartment of Integrative Physiology and Pathobiology, Tufts University School of Medicine, Boston, MA, USA.
H C OettgenDepartment of Medicine, Boston Children's Hospital, Boston, MA, USA.
Boston Children's Hospital · USTufts University · US

Funding

MOLECULAR BASIS OF ALLERGIC AND IMMUNOLOGIC DISEASET32AI007512 · NIAID · CHILDREN'S HOSPITAL BOSTON · PI Janet Chou, Peter A Nigrovic · 1996 to 2026
$13.1M
Mast cell regulation of Th2 induction and tolerance breakdown in food allergyR01AI119918 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI OETTGEN, HANS C · 2015 to 2025
$5.6M
IgG and Fc gamma receptor regulation of food allergy and oral toleranceK01DK106303 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI BURTON, OLIVER TEAL · 2015 to 2016
$256k
NIAID NIH HHS R01 AI119918NIAID NIH HHS T32 AI007512NIDDK NIH HHS K01 DK106303
6 · The paper itself

Abstract

backgroundMast cells serve an important sentinel function at mucosal barriers and have been implicated as key early inducers of type 2 immune responses in food allergy. The generation of Th2 and IgE following food allergen ingestion is inhibited in the absence of mast cells. Group 2 innate lymphoid cells are also thought to play an important early role in nascent allergic responses.

objectiveTo test whether IgE-mediated mast cell activation promotes intestinal ILC2 responses following ingestion of food allergens and whether ILC2 amplify food allergy.

methodsTwo different mouse models of food allergy, one using intraperitoneally ovalbumin (OVA)-primed BALB/c animals and the other using enterally peanut-sensitized inherently atopic IL4raF709 mice, were applied to test the contributions of IgE antibodies and mast cells to ILC2 responses. The effect of ILC2 on mast cell activation and on anaphylaxis was tested.

resultsILC2 responses were significantly impaired in both models of food allergy in Igh7 CONCLUSIONS AND CLINICAL RELEVANCE: These findings support an important role for IgE-activated mast cells in driving intestinal ILC2 expansion in food allergy and reveal that ILC2, in turn, can enhance responsiveness to the mediators of anaphylaxis produced by mast cells. Strategies designed to inhibit IgE signalling or mast cell activation are likely to inhibit both type 2 immunity and immediate hypersensitivity in food allergy.

Indexed as

AnimalsFood HypersensitivityImmunity, InnateImmunoglobulin EIntestinesLymphocyte ActivationLymphocytesMast CellsMiceMice, Inbred BALB CMice, Inbred C57BLImmunoglobulin Efood allergyIgEILC2mast cell

Identifiers

PMID29247574
PMCPMC5828976
OpenAlexW2771526014

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.